Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intestinal pseudoobstruction secondary to amyloidosis responsive to cisapride.

Literature DB >> 2007373

Intestinal pseudoobstruction secondary to amyloidosis responsive to cisapride.

Abstract

A case of chronic intestinal pseudoobstruction secondary to systemic amyloidosis in a patient with multiple myeloma is described. Gastrointestinal symptoms and indices of nutrition improved markedly after commencing treatment with cisapride, which may have been responsible for relatively prolonged survival compared with similar reported cases.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1991 PMID： 2007373 DOI： 10.1007/bf01298889

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

11 in total

1. Gastrointestinal-motility dysfunction in amyloidosis.

Authors: W M Battle; M R Rubin; S Cohen; W J Snape
Journal: N Engl J Med Date: 1979-07-05 Impact factor: 91.245

Review 2. Chronic intestinal pseudo-obstruction: diagnosis and treatment.

Authors: L J Colemont; M Camilleri
Journal: Mayo Clin Proc Date: 1989-01 Impact factor: 7.616

3. Amyloidosis and plasma cell dyscrasias: gastrointestinal involvement.

Authors: H C Carlson; J F Breen
Journal: Semin Roentgenol Date: 1986-04 Impact factor: 0.800

Review 4. Amyloidosis and the gut.

Authors: T Gilat; H M Spiro
Journal: Am J Dig Dis Date: 1968-07

Review 5. Place of surgery in the management of amyloid disease.

Authors: D P O'Doherty; J P Neoptolemos; K F Wood
Journal: Br J Surg Date: 1987-02 Impact factor: 6.939

6. Selective massive amyloidosis of small intestine.

Authors: B Griffel; B Man; L Kraus
Journal: Arch Surg Date: 1975-02

7. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings.

Authors: V Stanghellini; M Camilleri; J R Malagelada
Journal: Gut Date: 1987-01 Impact factor: 23.059

8. Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects.

Authors: C A Edwards; S Holden; C Brown; N W Read
Journal: Gut Date: 1987-01 Impact factor: 23.059

9. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.

Authors: M Camilleri; J R Malagelada; T L Abell; M L Brown; V Hench; A R Zinsmeister
Journal: Gastroenterology Date: 1989-03 Impact factor: 22.682

Review 10. Amyloidosis (AL). Clinical and laboratory features in 229 cases.

Authors: R A Kyle; P R Greipp
Journal: Mayo Clin Proc Date: 1983-10 Impact factor: 7.616

6 in total

1. Duodenal perforation in primary systemic amyloidosis.

Authors: A G Fraser; G I Nicholson
Journal: Gut Date: 1992-07 Impact factor: 23.059

2. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein.

Authors: S Tada; M Iida; T Yao; T Kitamoto; T Yao; M Fujishima
Journal: Gut Date: 1993-10 Impact factor: 23.059

3. Gastrointestinal amyloidosis secondary to hypersensitivity vasculitis presenting with intestinal pseudoobstruction.

Authors: K Hiramatsu; S Kaneko; Y Shirota; M Matsuda; K Kaji; Y Kitano; N Ikeda; S Terasaki; H Kawai; A Shimoda; H Yokoyama; E Matsushita; T Urabe; K Kobayashi
Journal: Dig Dis Sci Date: 1998-08 Impact factor: 3.199

Review 4. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders.

Authors: J Tack; G Coremans; J Janssens
Journal: Drug Saf Date: 1995-06 Impact factor: 5.606

Review 5. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors: L R Wiseman; D Faulds
Journal: Drugs Date: 1994-01 Impact factor: 9.546

Review 6. Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors.

Authors: J K DiBaise; E M Quigley
Journal: Dig Dis Sci Date: 1998-07 Impact factor: 3.487

6 in total